Screener
MoonLake Immunotherapeutics MLTX Q2 2026 earnings
Reported August 10, 2026 · Before market open
EPS-$0.84Beat by $0.07
EPS estimate-$0.91
Next report
Nov 4, 2026 (in a month)EPS estimate-$0.77
Versus estimates
Diluted EPS
FAQ
- When did MoonLake Immunotherapeutics report Q2 2026 earnings?
- MoonLake Immunotherapeutics (MLTX) reported Q2 2026 earnings on August 10, 2026 before market open.
- What were MoonLake Immunotherapeutics's Q2 2026 revenue and EPS?
- MoonLake Immunotherapeutics reported eps of $-0.84 for Q2 2026.
- Did MoonLake Immunotherapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.91 by $0.07.
- How did MoonLake Immunotherapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 3.4% from $-0.87.
- Where can I find MoonLake Immunotherapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-086939) and the 10-Q periodic report (0001821586-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.
